The AKRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The AKRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View AKRX Detailed Price Forecast - CNN Money||View AKRX Detailed Summary - Google Finance|
|View AKRX Detailed Summary - Yahoo! Finance||View AKRX Stock Research & Analysis - Zacks.com|
|View AKRX Trends & Analysis - Trade-Ideas||View AKRX Major Holders - Barrons|
|View AKRX Call Transcripts - NASDAQ||View AKRX Breaking News & Analysis - Seeking Alpha|
|View AKRX Annual Report - CompanySpotlight.com||View AKRX OTC Short Report - OTCShortReport.com|
|View AKRX Fundamentals - TradeKing||View AKRX SEC Filings - Bar Chart|
|View Historical Prices for AKRX - The WSJ||View Performance/Total Return for AKRX - Morningstar|
|View the Analyst Estimates for AKRX - MarketWatch||View the Earnings History for AKRX - CNBC|
|View the AKRX Earnings - StockMarketWatch||View AKRX Buy or Sell Recommendations - MacroAxis|
|View the AKRX Bullish Patterns - American Bulls||View AKRX Short Pain Metrics - ShortPainBot.com|
|View AKRX Stock Mentions - StockTwits||View AKRX Stock Mentions - PennyStockTweets|
|View AKRX Stock Mentions - Twitter||View AKRX Investment Forum News - Investor Hub|
|View AKRX Stock Mentions - Yahoo! Message Board||View AKRX Stock Mentions - Seeking Alpha|
|View Insider Transactions for AKRX - SECform4.com||View Insider Transactions for AKRX - Insider Cow|
|View AKRX Major Holdings Summary - CNBC||View Insider Disclosure for AKRX - OTC Markets|
|View Insider Transactions for AKRX - Yahoo! Finance||View Institutional Holdings for AKRX - NASDAQ|
|View AKRX Stock Insight & Charts - FinViz.com||View AKRX Investment Charts - StockCharts.com|
|View AKRX Stock Overview & Charts - BarChart||View AKRX User Generated Charts - Trading View|
RBC Is Bullish on Generic Pharma: Upgrades MYL, AMRX, ENDO, AKRX
Posted on Monday August 13, 2018
RBC Is Bullish on Generic Pharma: Upgrades MYL, AMRX, ENDO, AKRXRBC updates its view on the generic pharma industry
See what the IHS Markit Score report has to say about Akorn Inc.
Posted on Thursday August 09, 2018
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Factors of Influence in 2018, Key Indicators and Opportunity within Five Prime Therapeutics, Akorn, The Blackstone Group, Avaya, Tractor Supply, and CymaBay Therapeutics — New Research Emphasizes Economic Growth
Posted on Wednesday August 01, 2018
NEW YORK, Aug. 01, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Five ...
Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks
Posted on Tuesday July 31, 2018
WallStEquities.com revisits the Generic Drugs market, which can be segmented into biosimilars, simple generic, and super generic. Based on its therapeutics applications, the generic drugs market can be classified into cardiovascular products, anti-infective drugs, anti-arthritis drugs, central nervous system drugs, anti-cancer drugs, respiratory products, and others. Under assessment this morning are these four stocks: Agile Therapeutics Inc. (NASDAQ: AGRX), Akorn Inc. (NASDAQ: AKRX), Collegium Pharmaceutical Inc. (NASDAQ: COLL), and Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX).